[1] LI H，GUO J Z. Aliskiren-a novel rennin inhibitor[J] . Chin J New Durgs Clin Rem(中国新药与临床杂志)，2006，25(3)：216-219. [2] ZHANG A L，DU X L. Novel antihypertensive drug：aliskiren[J] . Chin Pharm J（中国药学杂志），2008，43（3）：237-238. [3] GRADMAN A H，KAD R. Renin inhibition in hypertension[J] . J Am Coll Cardiol，2008，51（5）：519-528. [4] Novartis Pharmaceuticals Corporation：Tekturna(aliskiren) [R] . NDA21-985，February，2007(T2007-05)(T2007-06). [5] GRADMAN A，KOLLOCH R E，MYERS M，et al. Aliskiren in combination with hydrochlorothiazide is effective and well tolerated during long-termtreatment of hypertension[J] . J Clin Hypertens，2007，9(5suppl A)：160. [6] KUSHIRO T，ITAKURA H，ABO Y，et al. Long-term safety and efficacy of aliskiren，an oral direct renin inhibitor，in Japanese patients with hypertension[J] . J Clin Hypertens，2007，9(5 Suppl A)：169. [7] OH B H，MITCHELL J，HERREON J R，et al. Aliskiren，an oral renin inhibitor，provides dose-dependent efficacy and sustained 24 h blood pressure control in patients. With hypertension[J] . J Am Coll Cardiol，2007，49(11)：1157-1163. [8] VAIDYANATHAN S，REYNOLDS C，YEH C M，et al. Pharmacokinetics，Safety，and Tolerability of the novel oral direct rennin inhibitor aliskiren in olderly healthy subjects[J] .J Clin Pharmacol，2007，47(4)：453-460. [9] ZHAO C，VAIDYANATHAN S，YEH C M，et al. Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus[J] . Clin Pharmacokinet，2006，45(11)：1125-1134. [10] URESIN Y，TAYLOR A，KILO C，et al. Aliskiren，a novel rennin inhibitor，has greater Bplowering than ramipril and additional Bplowering when combined with ramipril in patients with diabetes and hypertension[J] . J Hypertens，2006，24(Suppl 4)：82. [11] TAYLOR A，TSCHOPE D，KILO C，et al. Adding aliskiren to ramipril improves 24 h blood pressure control compared to ramipril alone in patients with diabetes and hypertension[J] . J Hypertens，2006，24(Suppl 4)：S81. [12] VAIDYANATHAN S，WARREN V，YEH C，et al. Pharmacokinetics，safety，and tolerability of the oral renin inhibitor aliskiren in patients with hepatic impairment[J] . J Clin Pharmacol，2007，47(2)：192-200. [13] PILZ B，SHAGDARSUREN E，WELLNER M，et al. Aliskiren，a human renin inhibitor，ameliorates cardiac and renal damage in double-transgenic rats[J] . Hypertension，2005，46(3)：569-576. [14] JORDAN J，ENGELI S，BOYE S W，et al. Direct renin inhibition with aliskiren in obese patients with arterial hypertension[J] . Hypertension，2007，49(5)：1047-1055. [15] KILO C，TAYLOR A，TSCHOEPE D，et al. Aliskiren，a novel rennin inhibitor for treatment of hypertension，enhances rennin system suppression by reducing plasma rennin activity alone or in combination with ramipril in patients with diabetes[J] . Eur Heart J，2006，25(Suppl)：118. [16] SEALEY J E，LARAGH J H. Aliskiren，the first rennin inhibitor for treating hypertension：Reactive rennin secretion may limit its effectiveness[J] . Am J Hypertens，2007，20：587-597. [17] VAIDYANATHAN S，JEMANY J，YEH C，et al. Aliskiren，a novel orally effective rennin inhibitor，exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects[J] . Br J Clin Pharmacol，2006，62(6)：690-698.